For Innovative “Gut Microbiome” Test, Elevating Holistic Healthcare
ViMUT Hospital, welcomes the Year of the Dragon with a dedicated commitment to advancing holistic healthcare. Under the “Outside In” strategy, the focus is on addressing health issues with maximum efficiency, precision, and comprehensiveness. The hospital aims to align with evolving lifestyles and modern health trends. In a significant move, ViMUT has partnered with AMILI, Southeast Asia’s pioneer in precision gut microbiome technology. This collaboration introduces innovative Gut Microbiome testing, positioning itself as a robust preventive care measure with the potential to avert diseases in the future.
ViMUT Hospital has also revealed the expansion of the microbiome market. It is optimistic that these advancements will improve medical services, fostering a more comprehensive healthcare approach and playing a crucial role in Thailand’s healthcare economy. The projected revenue for the Gastrointestinal and Liver Center at ViMUT Hospital in 2024 is expected to surge by over 30%, propelled by the ongoing development of comprehensive health services covering prevention, treatment, and rehabilitation.
The microbiome refers to the ecosystem of microorganisms residing in the digestive tract, serving as the body’s primary source of both helpful and harmful probiotics. When the Gut Microbiome is in balance, containing a diverse array of beneficial microorganisms, it aids in digestion, boosts metabolism, supports the immune system, synthesizes vitamins, and contributes to maintaining balance in the body and brain, promoting a positive mood.
Ongoing research indicates that maintaining a healthy balance in the gut microbiome can strengthen the overall immune system, preventing diseases and fostering good physical and mental health in the long run. Currently, the medical, scientific, and beauty fields worldwide are keenly interested in the health benefits associated with balancing the body’s microorganisms, both internally and externally.
Dr. Pichit Kangwolkij, Acting Chief Executive Officer – Vimut Hospital Company Limited said “In recent years, ViMUT Hospital has noted a growing awareness among Thai and global populations regarding proactive healthcare. The use of technology to analyze the gut microbiome stands out as a prominent trend in health. According to Research Reports World (RRW), the global microbiome market is anticipated to reach USD 743.21 million in 2022 and is expected to soar to USD 3.523.63 billion by 2028, showcasing a compound annual growth rate (CAGR) of 29.61%.”
“Adopting the Outside-In strategy, ViMUT Hospital is dedicated to exploring innovative approaches, aligning health services with market demands, and advancing business development with a user-centric focus. A strategic partnership has been established with AMILI, a leading health tech company from Singapore renowned for developing the most accurate gut microbiome technology in Southeast Asia. This collaboration introduces the Gut Microbiome Test, a program designed to assess the balance of intestinal microorganisms for individuals at the hospital.
The goal is to provide accurate diagnoses and treatments for patients. This initiative empowers doctors to recommend personalized microbial balance adjustments for each individual. Looking ahead, ViMUT Hospital aims to establish Thailand’s first gut microbiome research laboratory in collaboration with AMILI. This pioneering effort aims to elevate the standards of gut microbiome studies by using samples from the Thai population. The insights gathered will be instrumental in developing treatments and products tailored to the specific health needs of the Thai people. Currently, probiotic supplements are in development to enhance the treatment of gastrointestinal diseases, irritable bowel syndrome, and obesity,” added Dr. Pichit Kangwolkij.
Dr. Jeremy Lim, CEO & Co-Founder, AMILI, Southeast Asia’s first gut microbiome company based in Singapore, said, “AMILI houses Southeast Asia’s first and only gut microbiome transplant bank and is building the world’s largest multi-ethnic Asia gut microbiome database. Our development, “AMILI PRIME,” is a proprietary analysis tool meticulously designed for precise testing, diagnosis, and prediction algorithms for microbiome adjustments.
This collaboration underscores ViMUT Hospital’s commitment to advancing health services through innovative microbiome testing. Together, we aim to introduce gut health tests and Fecal Microbiota Transplantation (FMT) to the Thai market. AMILI is poised to collaborate with ViMUT in promoting well-being through innovation and cutting-edge technology, aligning with ViMUT Hospital’s pledge to ensure sustainable good health for the Thai population.”
Dr. Kulthep Rattanakovit, Director of Gastroenterology and Liver Department, ViMUT Hospital said “Many may not be aware that maintaining a balanced gut microbiome is crucial for the normal functioning of various systems in the body. An imbalance in intestinal microorganisms can lead to recurring health issues such as irritable bowel syndrome, constipation, and chronic diarrhea. Additionally, disrupted metabolism may increase the risk of obesity and result in unexplained immune system problems.
ViMUT Hospital’s Gut Microbiome Test employs stool testing to examine intestinal microorganisms. This allows specialists to analyze the balance and diversity of microorganisms in the intestines, facilitating the planning of adjustments for a healthier balance. This involves customizing diet and lifestyle changes for each patient. Moreover, based on individual microbial test results, probiotics with formulas and strains suitable for intestinal health may be recommended to maximize the benefits for that specific person, ensuring the utmost advantage from probiotics.
For individuals interested in the Gut Microbiome Test program to assess the balance of gut microorganisms, kindly reach out to the Gastrointestinal and Liver Center on the 5th floor of ViMUT Hospital. As part of the program launch, a special promotion is available with a starting price of 18,000 Baht per test. To schedule an appointment, please call 02-079-0034 between 7:00 a.m. and 5:00 p.m.